Dulaglutide-associated body odor with dechallenge and rechallenge in a patient with type 2 diabetes
Int. Journal of Clinical Pharmacology and Therapeutics · 01.08.2026 · 64 (08) · 455-458
DOI: 10.5414/cp204985 ↗Kurz gefasst
Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.08.2026. Verfasst von Srecko Marusic und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Hypoglycemic Agents, Recombinant Fusion Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Marusic, S., Staresinic, M., & Berkovic, M. C. (2026). Dulaglutide-associated body odor with dechallenge and rechallenge in a patient with type 2 diabetes. Int. Journal of Clinical Pharmacology and Therapeutics, 64(08), 455-458. https://doi.org/10.5414/cp204985
Vancouver
Marusic S, Staresinic M, Berkovic MC. Dulaglutide-associated body odor with dechallenge and rechallenge in a patient with type 2 diabetes. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(08):455-458. doi:10.5414/cp204985
BibTeX
@article{Marusic2026,
author = {Marusic, Srecko and Staresinic, Matea and Berkovic, Maja Cigrovski},
title = {Dulaglutide-associated body odor with dechallenge and rechallenge in a patient with type 2 diabetes},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {08},
pages = {455--458},
doi = {10.5414/cp204985}
}
EUVIMED